XML 23 R6.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Cash flows from operating activities    
Consolidated net income $ 16,380 $ 10,881
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 6,969 5,849
Impairment charges 24,311 0
Amortization of debt discount and debt issuance costs 1,315 1,411
Provision for allowances 3,270 1,550
Loss on early extinguishment of debt 1,568 0
Deferred income tax benefit (5,889) (1,387)
(Gain) loss on derivative liability (19,970) 385
Acquisition-related contingent consideration 662 0
Equity compensation 2,614 1,773
Loss on sale of business 0 2,184
Other non-cash costs 6 20
Changes in operating assets and liabilities:    
Accounts receivable (3,571) (13,927)
Prepaid expenses and other assets (1,036) 1,779
Income taxes (476) (407)
Accounts payable and accrued expenses 5,634 7,825
Other liabilities 482 930
Net cash provided by operating activities 32,269 18,866
Cash flows from investing activities    
Proceeds from sale of business 500 7,500
Acquisition-related settlements - Medical Staffing Network (2,155) (123)
Acquisition-related settlements - Mediscan 297 0
Transaction costs related to sale of business 0 (338)
Purchases of property and equipment (5,024) (1,790)
Net cash (used in) provided by investing activities (6,382) 5,249
Cash flows from financing activities    
Proceeds from borrowing on Senior Credit Facility 40,000 0
Debt issuance costs (1,182) 0
Principal payments on Second Lien Term Loan (30,000) 0
Extinguishment fees (641) 0
Repayments on Senior Secured Asset-Based revolving credit facility (65,200) (42,300)
Borrowings under Senior Secured Asset-Based revolving credit facility 57,200 38,800
Principal payment on Term Loan (500) 0
Repayments of capital lease obligations (60) (80)
Cash paid for shares withheld for taxes (603) (543)
Payment of contingent consideration (152) 0
Cash payments to noncontrolling shareholder (478) (353)
Net cash used in financing activities (1,616) (4,476)
Effect of exchange rate changes on cash (17) (50)
Change in cash and cash equivalents 24,254 19,589
Cash and cash equivalents at beginning of period 2,453 4,995
Cash and cash equivalents at end of period $ 26,707 $ 24,584